跳至主要内容
临床试验/CTRI/2024/03/064592
CTRI/2024/03/064592招募中3 期

Efficacy of Plasma Exchange Therapy vs Standard Medical Therapy in Severe Alcoholic Hepatitis With High Discriminant Function- A Randomized Controlled Trial. - NI

Institute of Liver and Biliary Sciences0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
招募中

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Age 18 to 60 years
  • 2.Severe alcoholic hepatitis with DFmore than 80 and less than 120 or MELD more than 30
  • 3.No liver transplant option available in near future(for atleast 1 month)
  • 4.Patient able to bear the cost of Plasma exchange by himself/herself

排除标准

  • 1.Active sepsis
  • 2.S creatinine more than 1.5mg per dl
  • 3.Chronic kidney disease
  • 4.Pregnancy
  • 5.HCC or any other malignancy
  • 6.Active Bleeding
  • 7.Allergic to replacement fluid (FFP) in TPE
  • 8.Severe Hypocalcemia (less than 7.6 mg per dl)
  • 9.Failure to give consent
  • 10.Financial issues to bear cost of Plasma exchange

研究者

相似试验